ND0612L: Phase IIa data

Top-line data from an Israeli Phase IIa trial in 16 advanced PD patients with motor fluctuations who were chronically treated with oral

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE